DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

Dexcom Inc. defeated investor allegations the glucose monitor maker exaggerated its ability to tap into the market of ...

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

DXCM continues to raise investor optimism due to its strong product portfolio. Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12. ...

The medical instruments industry is currently undergoing a transformative phase, thanks to the rapid adoption of generative ...

These athletes will receive free glucose monitors as well as mentoring from Dexcom's network of pro sports brand ambassadors.

The Oura Ring 4 is rapidly becoming the center piece of your efforts to lead a healthier life, and the introduction of two ...